David L. Lacey

Insider Reports History

Entity
Individual
Location
3280 Bayshore Boulevard, Brisbane, CA
Signature
/s/ Carolyn Tang, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David L. Lacey:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arcus Biosciences, Inc. Director Common Stock 57.7K $1.01M $17.55 Jun 6, 2024 Direct
Nurix Therapeutics, Inc. Director Director Stock Option (right to buy) 25K May 20, 2024 Direct
Arcus Biosciences, Inc. Director Stock Option (Right to Buy) 24K Jun 6, 2024 Direct
Atreca, Inc. Director Stock Option (right to buy) 12K Jun 13, 2023 Direct

Insider Reports Filed by David L. Lacey

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RCUS Arcus Biosciences, Inc. Jun 6, 2024 2 $0 4 Jun 7, 2024 Director
NRIX Nurix Therapeutics, Inc. May 20, 2024 1 $0 4 May 20, 2024 Director
RCUS Arcus Biosciences, Inc. Jun 15, 2023 2 $0 4 Jun 16, 2023 Director
BCEL Atreca, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
NRIX Nurix Therapeutics, Inc. May 4, 2023 1 $0 4 May 4, 2023 Director
RCUS Arcus Biosciences, Inc. Jun 14, 2022 2 $0 4 Jun 16, 2022 Director
BCEL Atreca, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
NRIX Nurix Therapeutics, Inc. May 5, 2022 1 $0 4 May 6, 2022 Director
BCEL Atreca, Inc. Jun 9, 2021 1 $0 4 Jun 11, 2021 Director
RCUS Arcus Biosciences, Inc. Jun 3, 2021 2 $0 4 Jun 7, 2021 Director
NRIX Nurix Therapeutics, Inc. May 6, 2021 1 $0 4 May 24, 2021 Director